A licensed healthcare provider should oversee any changes to your long-term treatment plan
Within the GLP-1 class, there are several different drugs, including liraglutide, semaglutide, and dulaglutide
Tirzepatide is a groundbreaking weekly injectable medication that sets itself apart by being a dual-agonist for two key hormone receptors: glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP)
A few pounds up or down at weigh-ins usually doesnt reflect a real change in progress
Heather Woolery-Lloyd explains that younger patients or those who lose modest amounts may see some natural tightening
When interpreted with a qualified healthcare provider, these predispositions can help explain why some patients respond robustly to GLP-1 therapy at lower doses, while others may require higher doses or combination approaches